Ticlopidine-induced marrow aplasia treated with cyclosporine

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 50-year-old diabetic and hypertensive male patient is reported who had ticlopidine-induced marrow aplasia partially responsive to colony-stimulating factors and corticosteroids, but experienced complete recovery with cyclosporine. There is no consensus on the treatment of ticlopidine-induced marrow aplasia. Although many cases are reported to recover with colony-stimulating factors and corticosteroids, others are unresponsive or partially responsive. Our patient also did not completely respond to these medications, but was successfully treated with cyclosporine alone. Alone or in combination with corticosteroids, cyclosporine is an effective drug of choice for the resistant patients.

Cite

CITATION STYLE

APA

Ertorer, M. E., Gokcel, A., Savas, L., & Kocak, R. (2002). Ticlopidine-induced marrow aplasia treated with cyclosporine. Clinical and Applied Thrombosis/Hemostasis, 8(2), 183–185. https://doi.org/10.1177/107602960200800216

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free